| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-28 |
| filingDate |
1998-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36d95ac1832e97af7713da49062e3d26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de197317f902fa77a937edb360704dfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06a66d2503c7c0626a60cbeb7eade53b |
| publicationDate |
1999-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H11228406-A |
| titleOfInvention |
Anti-influenza drug containing neuraminic acid compound |
| abstract |
(57) [Problem] The present invention relates to a sialidase inhibitor, a virus replication inhibitor comprising a neuraminic acid compound as an active ingredient, A therapeutic or prophylactic agent for a viral infection is provided. SOLUTION: The general formula: [Wherein R 1 is C 1- which may be substituted by a halogen atom. C 4 group; R 2, R 3 and R 4 are the same or different and each represents a hydrogen atom or a C 3 -C 25 aliphatic acyl group; W is a hydrogen atom or an ester residue. Provided that R 1 is a methyl group, and Except when R 2 , R 3 , R 4 and W are hydrogen atoms. ] Or a pharmacologically acceptable salt thereof as an active ingredient. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02092555-A1 |
| priorityDate |
1998-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |